| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 09/13/2000 | CN1056292C Eyesight improving granule and its preparation process |
| 09/12/2000 | US6118001 Anticancer agent; antiarthritic agent |
| 09/12/2000 | US6117912 Sublingual and buccal administration of selegiline for treating certain selegiline-responsive diseases and conditions |
| 09/12/2000 | US6117883 Useful for modulating a muscarinic receptor. |
| 09/12/2000 | US6117864 Methods employing stable preparation containing azelastine hydrochloride |
| 09/12/2000 | US6117862 Model and method for angiogenesis inhibition |
| 09/08/2000 | WO2000052210A2 Methods for targeting rna molecules |
| 09/08/2000 | WO2000052134A2 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | WO2000052051A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 09/08/2000 | WO2000052028A1 TUMOR NECROSIS FACTOR RECEPTORS 6α and 6$g(b) |
| 09/08/2000 | WO2000051979A1 C16 unsaturated fp-selective prostaglandins analogs |
| 09/08/2000 | WO2000051971A1 Oxamic acids and derivatives as thyroid receptor ligands |
| 09/08/2000 | WO2000051614A1 Inhibitors of prenyl-protein transferases |
| 09/08/2000 | WO2000051613A1 Upper hitch link |
| 09/08/2000 | WO2000051612A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | WO2000051611A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | WO2000051605A1 Compositions and methods for treating atopic dermatitis, angioedema and other disorders using antihistamines and glucocorticoids |
| 09/08/2000 | WO2000051595A1 Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using r(-)-ketoprofen |
| 09/08/2000 | WO2000051547A2 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | WO2000027414A3 Inhibition of the formation of vascular hyperpermeability |
| 09/08/2000 | WO1999034784A3 Pharmaceutical compositions comprising disulfiram for inhibiting angiogenesis |
| 09/08/2000 | CA2363169A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2363077A1 Methods for targeting rna molecules |
| 09/08/2000 | CA2362778A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2362495A1 Inhibitors of prenyl-protein transferases |
| 09/08/2000 | CA2362494A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2362493A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2362489A1 Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using r(-)-ketoprofen |
| 09/06/2000 | EP1032676A2 $i(CHLAMYDIA TRACHOMATIS) GENOMIC SEQUENCE AND POLYPEPTIDES, FRAGMENTS THEREOF AND USES THEREOF, IN PARTICULAR FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF INFECTION |
| 09/06/2000 | EP1032575A1 2,3-diaryl-pyrazolo(1,5-b)pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors |
| 09/06/2000 | EP1032561A1 Substituted oximes as neurokinin antagonists |
| 09/06/2000 | EP1032415A2 Composition for the treatment of allergic conditions having cysteine and serine proteinase inhibitory activity |
| 09/06/2000 | EP1032396A1 New composition of matter |
| 09/06/2000 | EP1032395A1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 09/06/2000 | CN1265669A Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265660A 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1H-indole derivatives |
| 09/06/2000 | CN1265658A 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application |
| 09/06/2000 | CN1265657A Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265652A 2-acrylaminopropanamines as tachykinin receptor antagonists |
| 09/06/2000 | CN1265647A Acrylic metalloprotease inhibitor |
| 09/06/2000 | CN1265645A Urokinase inhibitors |
| 09/06/2000 | CN1265590A Substituted alkanohydroxamic acid and method of reducing TNF 'alpha' levels |
| 09/05/2000 | US6114568 Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors |
| 09/05/2000 | US6114385 Administering l-carnitine, acyl l-carnitine derivatives or pharmacologically acceptable salts thereof for prophylaxis of diseases or treatment of cellular disorders caused by high levels of ceramide |
| 09/05/2000 | US6114372 Matrix metalloproteinase (mmp); tumor necrosis factor(tnf); compounds such as n2-((2s)-acetylmercapto)acetyl-5-phthalimidopentanoyl)-n1-((4 -methoxybenzene)sulphonyl)-n1-(phenylmethyl)hydrazine |
| 09/05/2000 | US6114367 Such as 3-(3-cyclopentyloxy-4-methoxy)phenyl-2-isoxazoline-5-hydroxamic acid; treating sepsis, septic shock, inflammatory bowel disease, tuberculosis, graft versus host disease or cachexia associated with aids or cancer in a mammal |
| 09/05/2000 | US6114361 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives |
| 09/05/2000 | US6114328 Isoxazoline and isoxazole fibrogen receptor antagonists |
| 09/05/2000 | US6114320 Therapeutic treatment for VEGF related ocular diseases |
| 09/05/2000 | US6114319 Compositions containing difluprednate |
| 09/05/2000 | US6114316 Combination of bisphosphonate and tetracycline |
| 09/05/2000 | US6113894 Treatment of blepharitis of the cornea of eyes, applying compositiion with viscosity adjusting agent, preservatives, buffers, nonionic surfactants and lipids |
| 08/31/2000 | WO2000050562A2 Dna encoding snorf25 receptor |
| 08/31/2000 | WO2000050400A1 2-aminopyridines containing fused ring substituents |
| 08/31/2000 | WO2000050395A1 Sulfonamide-containing indole compounds |
| 08/31/2000 | WO2000050040A1 Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula |
| 08/31/2000 | WO2000018910A9 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 08/31/2000 | WO2000012074A3 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase |
| 08/31/2000 | DE10008042A1 Neurokinin-1-Rezeptorantagonisten Neurokinin-1 receptor antagonists |
| 08/31/2000 | CA2363131A1 Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula |
| 08/31/2000 | CA2362906A1 Dna encoding snorf25 receptor |
| 08/30/2000 | EP1031347A1 Transnasal transport/immunisation with highly adaptable carriers |
| 08/30/2000 | EP1030851A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 08/30/2000 | EP1030845A1 Heterocyclic compounds having mmp and tnf inhibitory activity |
| 08/30/2000 | EP1030836A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 08/30/2000 | EP1030662A2 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists |
| 08/30/2000 | EP1030661A1 N,N-DIETHYLGLYCOLAMIDO ESTER PRODRUGS OF INDOLE sPLA 2? INHIBITORS |
| 08/30/2000 | EP0799198B1 Anti-inflammatory compounds |
| 08/30/2000 | CN1265114A Method for large-scale production of Di (uridine 5'-tetraphosphate) and salts thereof |
| 08/30/2000 | CN1265039A Use of texaphyrin in prepn. of medicament for use in ocular diagnosis and therapy |
| 08/30/2000 | CN1265032A Therapeutic and dietary compsns. containing essential fatty acids and bioactive disulphides |
| 08/29/2000 | US6111078 Staphylococcus aureus rsbU-1 |
| 08/29/2000 | US6110964 For treating arthritis, inflammatory bowel disease, crohn's disease, emphysema, acute respiratory distress syndrome, asthma chronic obstructive pulmonary disease, alzheimer's disease, organ transplant toxicity, cachexia, cancer |
| 08/29/2000 | US6110952 Preventing or treating nasal congestion, otitis media and sinusitis without undesired side effects, also asthma, pain, migraine, substance abuse and addiction, gastrointestinal disorder, ulcer, stomach hyperacidity |
| 08/29/2000 | US6110933 Amino acid derivatives and their use as phospholipase A2 inhibitor |
| 08/29/2000 | US6110926 Storage stable aqueous solution of naloxone hydrochloride mixed with a polyhydric alcohol; for opioid addiction testing |
| 08/29/2000 | US6110924 Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 08/29/2000 | US6110896 Peptidyl compounds and their therapeutic use |
| 08/24/2000 | WO2000048989A1 Mevinolin derivatives |
| 08/24/2000 | WO2000048603A1 DIBENZO-AZEPINE DERIVATIVES AS αV INTEGRIN RECEPTOR ANTAGONISTS |
| 08/24/2000 | WO2000048595A1 A novel anti-angiogenic agent comprising at least one kringle region and an upstream pre-activation domain of plasminogen |
| 08/24/2000 | WO2000048591A1 Combinations for the treatment of diseases involving angiogenesis |
| 08/24/2000 | WO2000048590A1 Substituted stilbene compounds with vascular damaging activity |
| 08/24/2000 | WO2000037470A8 Antihistaminic spiro compounds |
| 08/24/2000 | WO2000015797A3 Compositions and methods for the treatment of immune related diseases |
| 08/24/2000 | WO1999034763A3 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis |
| 08/24/2000 | WO1998024898A3 Therapeutic composition comprising the kal protein and use of the kal protein |
| 08/24/2000 | CA2362538A1 Secreted proteins and polynucleotides encoding them |
| 08/24/2000 | CA2362334A1 Dibenzo-azepine derivatives as .alpha.v integrin receptor antagonists |
| 08/24/2000 | CA2362330A1 A novel anti-angiogenic agent comprising at least one kringle region and an upstream pre-activation domain of plasminogen |
| 08/23/2000 | EP1028957A1 Piperidine derivatives and their use as tachykinin antagonists |
| 08/23/2000 | EP1028956A1 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom |
| 08/23/2000 | EP1028948A1 Phenyl-alkyl-imidazoles as h3 receptor antagonists |
| 08/23/2000 | EP1028947A1 H3 receptor ligands of the phenyl-alkyl-imidazoles type |
| 08/23/2000 | EP1028945A1 Substituted pyridine compounds as anti-inflammatory agents |
| 08/23/2000 | EP1028725A1 Application of vasopressin antagonists for treating disturbances or illnesses of the inner ear |
| 08/23/2000 | EP1028707A1 Sustained release ophthalmic compositions containing water soluble medicaments |
| 08/23/2000 | EP0821668B1 Derivatives of succinamide and their use as metalloproteinase inhibitor |
| 08/23/2000 | CN1055700C Therapeutic peptide derivatives |
| 08/22/2000 | US6107338 Aromatic C16 -C20 -substituted tetrahydro prostaglandins useful as FP agonists |